» Articles » PMID: 38694557

Resveratrol Inhibits Calcium Oxalate Crystal Growth, Reduces Adhesion to Renal Cells and Induces Crystal Internalization into the Cells, but Promotes Crystal Aggregation

Overview
Date 2024 May 2
PMID 38694557
Authors
Affiliations
Soon will be listed here.
Abstract

Resveratrol is a natural phenolic compound that belongs to stilbenoid group found in diverse plants. Health benefits and therapeutic potentials of resveratrol have been widely recognized in various diseases. In kidney stone disease, it can alleviate oxalate-induced hyperproduction of free radicals in renal epithelial cells. Nevertheless, its direct effects on calcium oxalate (CaOx) crystal, which is the major stone component, remained unclear. This study therefore addressed the direct effects of resveratrol (at 1, 10 or 100 μM) on each step of CaOx kidney stone formation. The results revealed that resveratrol had no significant effects on CaOx crystallization. However, resveratrol significantly decreased CaOx crystal growth and adhesion to renal epithelial cells at all concentrations, and induced crystal internalization into the cells (a process related to crystal degradation by endolysosomes) in a concentration-dependent manner. On the other hand, resveratrol promoted crystal aggregation. These data indicate that resveratrol serves as a dual modulator on CaOx stone formation. While it inhibits CaOx stone development by reducing crystal growth and adhesion to renal cells and by inducing crystal internalization into the cells, resveratrol promotes crystal aggregation, which is one of the mechanisms leading to kidney stone formation.

References
1.
Fong-Ngern K, Sueksakit K, Thongboonkerd V . Surface heat shock protein 90 serves as a potential receptor for calcium oxalate crystal on apical membrane of renal tubular epithelial cells. J Biol Inorg Chem. 2016; 21(4):463-74. DOI: 10.1007/s00775-016-1355-x. View

2.
He J, Deng S, Ouyang J . Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of healthy persons and lithogenic patients. IEEE Trans Nanobioscience. 2010; 9(2):156-63. DOI: 10.1109/TNB.2010.2045510. View

3.
Thongboonkerd V, Semangoen T, Chutipongtanate S . Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature. Clin Chim Acta. 2006; 367(1-2):120-31. DOI: 10.1016/j.cca.2005.11.033. View

4.
Chow K, Dixon J, Gilpin S, Kavanagh J, Rao P . Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones. Kidney Int. 2004; 65(5):1724-30. DOI: 10.1111/j.1523-1755.2004.00566.x. View

5.
Li W, Yuan H, Liu Y, Wang B, Xu X, Xu X . Current analytical strategies for the determination of resveratrol in foods. Food Chem. 2023; 431:137182. DOI: 10.1016/j.foodchem.2023.137182. View